Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test

NCT05025644 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05025644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05025644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2023
Completion date
November 30, 2024
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic obstructive cardiomyopathy